Sunitinib Malate and Exemestane in Treating Postmenopausal Women With Breast Cancer

NCT00931450 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

70

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: exemestane
DRUG: sunitinib malate
OTHER: placebo

Sponsor

Institut Català d'Oncologia